Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2-Reference-Cited by-同舟云学术

Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2

Published:2023-09 Issue: Volume:217 Page:105677
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bowden-Reid Ellen,Ledger Scott,Zhang Yuan,Di Giallonardo Francesca,Aggarwal Anupriya,Stella Alberto Ospina,Akerman Anouschka^ORCID,Milogiannakis Vanessa^ORCID,Walker Gregory,Rawlinson William^ORCID,Turville Stuart,Kelleher Anthony D.,Ahlenstiel Chantelle^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference36 articles.

1. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia;Aggarwal;Nat Microbiol,2022

2. SARS-CoV-2 Omicron BA.5: evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern;Aggarwal;EBioMedicine,2022

3. Controlling HIV-1: non-coding RNA gene therapy approaches to a functional cure;Ahlenstiel;Front. Immunol.,2015

4. Novel RNA duplex locks HIV-1 in a latent state via chromatin-mediated transcriptional silencing;Ahlenstiel;Mol. Ther. Nucleic Acids,2015

5. Overview of SARS-CoV-2 genome-encoded proteins;Bai;Sci. China Life Sci.,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting functional regions in the viral RNA genome as druggable entities;2024-08-11

2. Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral Sequences;Viruses;2024-07-03

3. “Outlaw” mutations in quasispecies of SARS-CoV-2 inhibit replication;Emerging Microbes & Infections;2024-06-25

4. Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses;Antiviral Research;2024-06

5. RNAi-mediated inhibition of SARS-CoV-2: applications and challenges;Future Virology;2024-03-03